#ClinicalResearch Archives

Assessing the Impact of Omicron Variant on Allo-HSCT Recipients in China: Insights from a Single-Center Observational Study

By Mourabit Halima 2024.03.17

Introduction: The emergence of the Omicron variant of SARS-CoV-2 has posed significant challenges to global public health systems. Among vulnerable populations, allo-hematopoietic stem cell transplantation (allo-HSCT) recipients represent a particularly…

The Complex Impact of CMV Reactivation Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Comprehensive Review

By Qingyuan Liu 2024.03.17

Abstract: Cytomegalovirus (CMV) reactivation presents a formidable challenge for patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), with implications for overall mortality (OM) and non-relapse mortality (NRM) that are subject…

Voice of China | Professor Jidong Jia and Professor Hong You’s Team: Carvedilol Combined with Antiviral Treatment Can Delay the Progression of Moderat

By Mourabit Halima 2024.01.17

Editor's Note: Portal hypertension is the main pathophysiological cause of decompensation events in patients with cirrhosis and is a major driver of liver function deterioration. Non-selective β-blockers (NSBBs) are widely…